Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT00998946 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, B-Cell

Interventions

DRUG: Pralatrexate
DIETARY_SUPPLEMENT: Vitamin B12
DIETARY_SUPPLEMENT: Folic Acid

Sponsor

Spectrum Pharmaceuticals, Inc